OSR Health Issues Clarification Regarding Prior Nasdaq Communication and Shareholder Loyalty CVR Program

(High)

(Positive)

Rhea-AI Summary

OSR Health (NASDAQ:OSRH) issued a clarification regarding its earlier communication about Nasdaq and its Shareholder Loyalty CVR Program. The company stated that a prior description of Nasdaq’s feedback should not be taken as Nasdaq approval or endorsement. Nasdaq’s input was limited to a preliminary, verbal view on mechanical stock price adjustments. OSR Health confirmed the August 14, 2026 record date and indicated that program details and enrollment information remain available on its website.

Market Context

The platform record for OSRH showed mixed outcomes around loyalty-program communications, adding con...

Analysis

The platform record for OSRH showed mixed outcomes around loyalty-program communications, adding context to this clarification. The principal watchpoint remained Nasdaq's limited view and the company's scheduled record date; short positioning was categorized as low.

Key Figures

Prior release date: July 31, 2026 Record date: August 14, 2026

2 metrics

Prior release date July 31, 2026 Release clarified in the announcement

Record date August 14, 2026 Previously announced Shareholder Loyalty CVR Program record date

Historical Context

5 past events · Latest: Aug 03 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 03	Clinical data publication	Positive	-0.4%	Announced forthcoming VXM01 clinical publication with reported safety and immune-activation findings.
Jul 31	Nasdaq communication	Positive	+4.2%	Nasdaq communication described no mechanical price adjustment for the loyalty CVR program.
Jul 13	CEO shareholder message	Positive	+8.4%	CEO outlined CVR tiers offering potential additional shares subject to price and holding milestones.
Jul 02	Research report	Positive	+3.4%	Research report reiterated rating and price target while highlighting loyalty-program and licensing catalysts.
Jun 25	Loyalty program launch	Positive	-4.9%	Announced CVRs with price tiers, holding requirements, and potential additional-share distributions.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Positive-leaning announcements aligned with gains in three of five recent events, while two announcements diverged.

Key Terms

cvr, ex-date adjustment, record date

3 terms

cvr financial

"Shareholder Loyalty CVR Program"

A CVR (Contingent Value Right) is a contract-like entitlement issued in corporate transactions that pays the holder additional cash or shares only if specified future events or milestones occur, such as regulatory approval, sales targets, or performance thresholds. Think of it like a coupon that becomes valuable only if a company hits agreed goals; for investors it changes the risk-reward mix of a deal by offering potential upside tied to uncertain future outcomes and can affect valuation, liquidity and expected returns.

ex-date adjustment financial

"such as an ex-date adjustment"

Ex-date adjustment is the change made to a stock price, index level, or related contracts on the ex-dividend, ex-rights, or other corporate-action date to reflect the value being paid out or redistributed (for example a cash dividend, stock dividend, or split). It matters to investors because it preserves fair comparisons and accounting — like removing the value of a coupon from a product's sticker price so the listed price reflects what remains after the payout.

record date financial

"previously announced August 14, 2026 record date"

The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

08/07/2026 - 03:00 PM

BELLEVUE, WA / ACCESS Newswire / August 7, 2026 / OSR Health, Inc. (NASDAQ:OSRH) ("OSR Health" or the "Company") today issued a clarification regarding its press release dated July 31, 2026 concerning the Nasdaq Stock Market ("Nasdaq") and the Company's Shareholder Loyalty CVR Program.

The Company is clarifying that the statement in the prior release, "The communication affirms that our loyalty program is additive and gives shareholders clarity," should not be interpreted as indicating that Nasdaq has approved or endorsed the Shareholder Loyalty CVR Program.

Nasdaq's earlier communication was a preliminary, verbal indication limited to the technical question of whether the program would result in a mechanical adjustment to the price of OSRH common stock (such as an ex-date adjustment). Other than that, Nasdaq has not expressed any definitive opinion regarding the program.

This clarification does not change the Company's previously announced August 14, 2026 record date for the Shareholder Loyalty CVR Program. Program details, eligibility, and enrollment information remain available at www.osr-health.com/loyaltyprogram.

The Company will update shareholders as matters progress.

About OSR Health
OSR Health, Inc. (NASDAQ:OSRH) is a global healthcare holding company dedicated to advancing biomedical innovations in health and wellness. Through its subsidiaries, OSR Health engages in immuno-oncology, regenerative biologics, and medical device technologies to improve health outcomes worldwide. Learn more at www.osr-health.com

Investor Contact
OSR Health, Inc.
Investor Relations
ir@osr-health.com

Forward-Looking Statements
This press release contains forward-looking statements, including statements regarding the Shareholder Loyalty CVR Program and the Company's regulatory and securities-law processes. These statements are subject to risks and uncertainties, including the outcome and timing of the Company's pending SEC no-action request, Nasdaq's ultimate position on the program, the satisfaction of the program's holding-period and price conditions, the Company's continued listing on Nasdaq, and other factors described in the Company's SEC filings. Actual results may differ materially. The Company undertakes no obligation to update any forward-looking statement except as required by law. This release does not constitute an offer to sell or a solicitation to buy any securities.

SOURCE: OSR Health, Inc.

View the original press release on ACCESS Newswire

FAQ

What clarification did OSR Health (OSRH) provide about Nasdaq and its Shareholder Loyalty CVR Program on August 7, 2026?

OSR Health clarified that Nasdaq has not approved or endorsed its Shareholder Loyalty CVR Program. According to OSR Health, Nasdaq only gave a preliminary verbal indication on whether the program would trigger mechanical stock price adjustments, such as an ex-date adjustment, and offered no broader opinion.

Did Nasdaq approve OSR Health’s Shareholder Loyalty CVR Program for OSRH shareholders?

No, Nasdaq did not approve or endorse OSR Health’s Shareholder Loyalty CVR Program. According to OSR Health, Nasdaq’s earlier feedback was limited to a technical, preliminary verbal view on possible mechanical price adjustments and did not address the program’s overall merits or structure.

What is the record date for OSR Health’s Shareholder Loyalty CVR Program for OSRH stockholders?

The record date for OSR Health’s Shareholder Loyalty CVR Program is August 14, 2026. According to OSR Health, this previously announced record date remains unchanged by the clarification, and shareholders can review eligibility and enrollment details on the company’s dedicated loyalty program webpage.

Where can OSRH investors find details and enrollment information for OSR Health’s Shareholder Loyalty CVR Program?

OSRH investors can find details and enrollment information on OSR Health’s loyalty program webpage. According to OSR Health, the site provides program terms, eligibility criteria, and participation steps and remains the primary resource while the company continues updating shareholders as matters progress.

How does OSR Health describe Nasdaq’s communication regarding potential stock price adjustments related to OSRH’s loyalty CVR program?

OSR Health describes Nasdaq’s communication as a preliminary, verbal indication focused on mechanical price adjustments. According to OSR Health, Nasdaq addressed whether the loyalty CVR program might cause adjustments such as an ex-date change and has given no definitive opinion beyond that technical question.